<DOC>
	<DOCNO>NCT00835848</DOCNO>
	<brief_summary>Both pre- postconditioning seem protect cardiomyocytes reperfusion therapy . Investigations ex vivo vivo suggest gut derive hormone , Glucagon-Like-Peptide-1 ( GLP-1 ) , able reduce reperfusioninjury myocardial ischemia . Results laboratory show marked reduction infarct size rat heart Langendorf preparation expose GLP-1 analogue , exendin-4 . The investigator want investigate extent effect translate human set acute STEMI treat primary PCI evalutaed cardiac magnetic resonance imaging .</brief_summary>
	<brief_title>Pharmacological Postconditioning Reduce Infarct Size Following Primary PCI</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>More 18 year age . STEMI le 12 hour onset pain . STEMI define STsegment elevation 2 contiguous electrocardiographic lead &gt; 0.1 mV V4 V6 limb lead II , III aVF , &gt; 0.2 mV lead V1 V3 . TIMI 01 infarct relate artery . Oral write informed consent . Multivessel disease define one stenoses &gt; 70 % diameter non infarct relate artery . Previous myocardial infarction . Stent trombosis . Previous CABG . Less TIMI 2 follow wire predilatation infarct relate artery prior postconditioning placebo treatment . Renal insufficiency ( creatinin &gt; 200 ) . Pregnancy lactation . Diabetic ketoacidose eller hypoglycemia ( plasma glukose &lt; 2.5 mmol/l ) . Pancreatitis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>ST-segment elevation myocardial infarction</keyword>
	<keyword>Primary PCI</keyword>
	<keyword>Postconditioning</keyword>
</DOC>